Improving survival after endometrial cancer: the big picture
- PMID: 26197859
- PMCID: PMC4510340
- DOI: 10.3802/jgo.2015.26.3.227
Improving survival after endometrial cancer: the big picture
Abstract
To improve survival in women with endometrial cancer, we need to look at the "big picture" beyond initial treatment. Although the majority of women will be diagnosed with early stage disease and are cured with surgery alone, there is a subgroup of women with advanced and high-risk early stage disease whose life expectancy may be prolonged with the addition of chemotherapy. Immunohistochemistry will help to identify those women with Lynch syndrome who will benefit from more frequent colorectal cancer surveillance and genetic counseling. If they happen to be diagnosed with colorectal cancer, this information has an important therapeutic implication. And finally, because the majority of women will survive their diagnosis of endometrial cancer, they remain at risk for breast and colorectal cancer, so these women should be counselled about screening for these cancers. These three interventions will contribute to improving the overall survival of women with endometrial cancer.
Keywords: Colorectal Neoplasms, Hereditary Nonpolyposis; Endometrial Neoplasms.
Conflict of interest statement
Similar articles
-
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.Obstet Gynecol. 2005 Mar;105(3):569-74. doi: 10.1097/01.AOG.0000154885.44002.ae. Obstet Gynecol. 2005. PMID: 15738026
-
Genetic counseling and cascade genetic testing in Lynch syndrome.Fam Cancer. 2016 Jul;15(3):423-7. doi: 10.1007/s10689-016-9893-5. Fam Cancer. 2016. PMID: 26969309
-
Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.Curr Opin Obstet Gynecol. 2009 Feb;21(1):31-8. doi: 10.1097/GCO.0b013e32831c844d. Curr Opin Obstet Gynecol. 2009. PMID: 19125001 Review.
-
Lynch syndrome.Clin Obstet Gynecol. 2011 Jun;54(2):199-214. doi: 10.1097/GRF.0b013e3182185a41. Clin Obstet Gynecol. 2011. PMID: 21508689 Review.
-
Follow-up recommendations and risk-reduction initiatives for Lynch syndrome.Expert Rev Anticancer Ther. 2012 Oct;12(10):1359-67. doi: 10.1586/era.12.114. Expert Rev Anticancer Ther. 2012. PMID: 23176623 Review.
Cited by
-
MicroRNA-183 correlates cancer prognosis, regulates cancer proliferation and bufalin sensitivity in epithelial ovarian caner.Am J Transl Res. 2016 Apr 15;8(4):1748-55. eCollection 2016. Am J Transl Res. 2016. PMID: 27186298 Free PMC article.
-
Identification of an Anoikis-associated LncRNA Signature to Predict the Clinical Prognosis and Immune Function of Patients with Endometrial Cancer.Int J Med Sci. 2025 May 7;22(10):2502-2517. doi: 10.7150/ijms.107243. eCollection 2025. Int J Med Sci. 2025. PMID: 40386064 Free PMC article.
-
Evaluating the impact of universal Lynch syndrome screening in a publicly funded healthcare system.Cancer Med. 2020 Sep;9(18):6507-6514. doi: 10.1002/cam4.3279. Epub 2020 Jul 23. Cancer Med. 2020. PMID: 32700475 Free PMC article.
-
The expression of asparaginyl endopeptidase promotes growth potential in epithelial ovarian cancer.Cancer Biol Ther. 2017 Apr 3;18(4):222-228. doi: 10.1080/15384047.2017.1294290. Epub 2017 Mar 3. Cancer Biol Ther. 2017. PMID: 28278071 Free PMC article.
-
Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients.J Oncol. 2021 Dec 28;2021:3375297. doi: 10.1155/2021/3375297. eCollection 2021. J Oncol. 2021. PMID: 34992654 Free PMC article.
References
-
- Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11:1531–1543. - PubMed
-
- Weiderpass E, Gridley G, Persson I, Nyren O, Ekbom A, Adami HO. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer. 1997;71:360–363. - PubMed
-
- Shoff SM, Newcomb PA. Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol. 1998;148:234–240. - PubMed
-
- Parazzini F, La Vecchia C, Negri E, Riboldi GL, Surace M, Benzi G, et al. Diabetes and endometrial cancer: an Italian case-control study. Int J Cancer. 1999;81:539–542. - PubMed
-
- Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, Escudero-De los Rios P, Salmeron-Castro J, Larrea F, et al. Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control. 2000;11:707–711. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources